Dermatofibrosarcoma protuberans: Recurrence is related to the adequacy of surgical margins

European Journal of Surgical Oncology

Volumn 36, Issue 1, 2010, Pages 89-94

  Heuvel, S Ten ^a   Suurmeijer, A ^a   Pras, E ^a   Van Ginkel, R J ^a   Hoekstra, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dermatofibrosarcoma protuberans; Imatinib; Pathology; Prognosis; Radiation; Surgery

Indexed keywords

CD34 ANTIGEN; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE FREE SURVIVAL; EXCISION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMB PERFUSION; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; RECURRENCE RISK; RISK REDUCTION; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; CHILD; DERMATOFIBROSARCOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SKIN NEOPLASMS; YOUNG ADULT;

EID: 73249147636     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.07.006     Document Type: Article

References (35)

1. Kleihues P., and Sobin L. Dermatofibrosarcoma protuberans. In: LeBoit P.E., Burg G., Weedon D., and Sarasin A. (Eds). World Health Organization classification of tumours: pathology and genetics of skin tumors (2007), IARC Press, Lyon 259-261
2. Toro J.R., Travis L.B., Wu H.J., et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer 19 (2006) 2922-2930
3. Mendenhall W.M., Zlotecki R.A., and Scarborough M.T. Dermatofibrosarcoma protuberans. Cancer 101 (2004) 2503-2508
4. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 28 (1993) 613-617
5. Abenoza P., and Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 15 (1993) 429-434
6. Abbott J.J., Oliveira A.M., and Nascimento A.G. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol 30 (2006) 436-443
7. Mentzel T., Beham A., Katenkamp D., et al. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 22 (1998) 576-587
8. Sandberg A.A., and Bridge J.A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet 140 (2003) 1-12
9. Rutgers E.J., Kroon B.B., Albus-Lutter C.E., et al. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 18 (1992) 241-248
10. Häfner H.M., Moehrle M., Eder S., et al. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome. Eur J Surg Oncol 34 (2008) 680-686
11. McArthur G.A., Demetri G.D., van Oosterom A., et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: imatinib target exploration consortium study B225. J Clin Oncol 23 (2005) 866-873
12. Van Ginkel R.J., Thijssens K.M., Pras E., et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation. Ann Surg Oncol 14 (2007) 1499-1506
13. Monnier D., Vidal C., Martin L., et al. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol 20 (2006) 1237-1242
14. Lindner N.J., Scarborough M.T., Powell G.J., et al. Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol 25 (1999) 392-397
15. Bowne W.B., Antonescu C.R., Leung D.H., et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 88 (2000) 2711-2720
16. Chang C.K., Jacobs I.A., and Salti G.I. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 30 (2004) 341-345
17. DuBay D., Cimmino V., Lowe L., et al. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 100 (2004) 1008-1016
18. Fiore M., Miceli R., Mussi C., et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 23 (2005) 7669-7675
19. Lemm D., Mügge L.O., Mentzel T., et al. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol 135 (2009) 653-665
20. Swan M.C., Banwell P.E., Hollowood K., et al. Late recurrence of dermatofibrosarcoma protuberans in the female breast: a case report. Br J Plast Surg 58 (2005) 84-87
21. Orlando R., Lumachi F., and Lirussi F. Recurrent dermatofibrosarcoma protuberans sixteen years after radical excition. A case report. Anticancer Res 23 (2003) 4233-4234
22. Khatri V.P., Galante J.M., Bold R.J., et al. Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment. Ann Surg Oncol 10 (2003) 1118-1122
23. Kimmel Z., Ratner D., Kim J.Y., et al. Peripheral excision margins for dermatofibrosarcoma protuberans: a meta-analysis of spatial data. Ann Surg Oncol 14 (2007) 2113-2120
24. Ballo M.T., Zagars G.K., Pisters P., et al. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 40 (1998) 823-827
25. Suit H., Spiro I., Mankin H.J., et al. Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol 14 (1996) 2365-2369
26. Dagan R., Morris C.G., Zlotecki R.A., et al. Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol 28 (2005) 537-539
27. Haas R.L., Keus R.B., Loftus B.M., et al. The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group. Eur J Cancer 33 (1997) 1055-1060
28. Snow S.N., Gordon E.M., Larson P.O., et al. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer 101 1 (2004 Jul 1) 28-38
29. Massey R.A., Tok J., Strippoli B.A., et al. A comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans. Dermatol Surg 24 (1998) 995-998
30. Garcia C., Viehman G., Hitchcock M., et al. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability. Dermatol Surg 22 (1996) 177-179
31. Brabant B., Revol M., Vergote T., et al. Dermatofibrosarcoma protuberans of the chest and the shoulder: wide and deep excision with immediate reconstruction. Plast Reconstr Surg 92 (1993) 459-462
32. Arnaud E.J., Perrault M., Revol M., et al. Surgical treatment of dermatofibrosarcoma protuberans. Plast Reconstr Surg 100 (1997) 884-895
33. Mehrany K., Swanson N.A., Heinrich M.C., et al. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy. Dermatol Surg 32 (2006) 456-459
34. Sirvent N., Maire G., and Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37 (2003) 1-19
35. Labropoulos S.V., Fletcher J.A., Oliveira A.M., et al. Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs 16 (2005) 461-466